Novo Integrated Sciences Inc
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, … Read more
Novo Integrated Sciences Inc (NVOS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of November 2024: -0.037x
Based on the latest financial reports, Novo Integrated Sciences Inc (NVOS) has a cash flow conversion efficiency ratio of -0.037x as of November 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-545.92K) by net assets ($14.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Novo Integrated Sciences Inc - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Novo Integrated Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Novo Integrated Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novo Integrated Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VTCHF
PINK:VTCHF
|
N/A |
|
Community Bankers' Corporation
PINK:CTYP
|
0.121x |
|
Lenskart Solutions Ltd
NSE:LENSKART
|
N/A |
|
Sebang Co. Ltd. Pfd. Series 1
KQ:004365
|
N/A |
|
Income Financial Trust
TO:INC-UN
|
0.017x |
|
Nwai
WAR:NWA
|
N/A |
|
QLOSR GROUP AB AK B
F:Y57
|
N/A |
|
Branded Legacy Inc
PINK:BLEG
|
-0.014x |
Annual Cash Flow Conversion Efficiency for Novo Integrated Sciences Inc (2004–2024)
The table below shows the annual cash flow conversion efficiency of Novo Integrated Sciences Inc from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-08-31 | $14.61 Million | $-2.24 Million | -0.154x | -67.64% |
| 2023-08-31 | $24.50 Million | $-2.24 Million | -0.092x | +30.86% |
| 2022-08-31 | $44.43 Million | $-5.88 Million | -0.132x | -466.11% |
| 2021-08-31 | $43.80 Million | $-1.02 Million | -0.023x | -56.63% |
| 2020-08-31 | $29.57 Million | $-441.69K | -0.015x | +53.60% |
| 2019-08-31 | $25.54 Million | $-822.27K | -0.032x | +99.40% |
| 2018-08-31 | $172.77K | $-934.50K | -5.409x | -2961.09% |
| 2017-08-31 | $-4.29 Million | $-810.69K | 0.189x | +1419.42% |
| 2016-09-30 | $-7.08 Million | $101.39K | -0.014x | +99.88% |
| 2016-08-31 | $14.75K | $-175.62K | -11.904x | -5235.68% |
| 2015-08-31 | $-625.67K | $-145.03K | 0.232x | -11.88% |
| 2014-08-31 | $-947.87K | $-249.32K | 0.263x | -40.10% |
| 2013-08-31 | $-797.36K | $-350.12K | 0.439x | +126.25% |
| 2012-08-31 | $-2.33 Million | $-451.84K | 0.194x | -81.37% |
| 2011-08-31 | $-1.49 Million | $-1.55 Million | 1.042x | +30.39% |
| 2010-08-31 | $-1.19 Million | $-951.79K | 0.799x | +273.71% |
| 2009-08-31 | $-1.44 Million | $-307.59K | 0.214x | -62.94% |
| 2008-08-31 | $-844.10K | $-486.89K | 0.577x | -62.45% |
| 2007-08-31 | $-296.61K | $-455.65K | 1.536x | +407.69% |
| 2006-08-31 | $-409.22K | $-123.83K | 0.303x | +21.80% |
| 2005-08-31 | $-305.08K | $-75.79K | 0.248x | 0.00% |
| 2004-08-31 | $-305.08K | $-75.79K | 0.248x | -- |